On August 23, 2012, the Board of BioPorto decided to partially exercise the authorization in the Company Articles to carry out a cash issue, private placement to a limited number of investors. On September 21, 2012, the Board allocated the shares, see company announcement no 17 of the same date.
During the subscription period, the company received binding acceptance of subscription from two investors. BioPorto has not yet received the full subscription amount and has given a brief extension of the payment deadline. A clarification of the situation and a decision on whether the issue is implemented or implemented in part will take place before the end of October 2012.
For further information, please contact:
Thea Olesen, CEO
Christina Thomsen, Investor Relations
Telephone +45 4529 0000, e-mail investor@bioporto.com
